Wells Fargo & Company »

Maplight Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $328k 19k 17.57